Get Your Personalized Supplement StackSupplement Stack Quiz

Cinchona

Also known as: Cinchona, Quinine, Cinchona succirubra

Overview

Cinchona is a genus of trees native to South America, historically recognized as the primary natural source of quinine, a potent antimalarial alkaloid. The bark of Cinchona trees contains various bitter compounds, including quinine and related alkaloids. While traditionally used for treating malaria, recent research has explored cinchona extracts as nutraceuticals, particularly for their potential role in weight management and metabolic health. This emerging interest stems from their bitter taste agonist properties, which may influence appetite and satiety. The research on cinchona for metabolic benefits is still in its early stages, with moderate maturity and limited clinical trial data. There are currently no comprehensive systematic reviews or meta-analyses specifically on cinchona supplementation for weight loss or metabolic effects, indicating a need for further robust studies to solidify its efficacy and safety in these applications.

Benefits

Preliminary evidence suggests that *Cinchona succirubra* supplementation, when combined with a hypocaloric diet, may offer benefits for weight management and body composition. A randomized controlled trial (RCT) involving 59 overweight/obese adults demonstrated that 60 days of supplementation led to significantly greater reductions in body weight, BMI, waist and hip circumference, and fat mass percentage compared to a placebo group on the same diet. The cinchona group also showed improvements in fat-free mass and total body water percentage, indicating a more favorable body composition. Additionally, the study reported improved satiety and stable cholecystokinin levels, suggesting a potential mechanism for appetite regulation. While promising, these findings are based on a single moderate-quality RCT, and there are no systematic reviews or meta-analyses to provide broader support. Historically, quinine, derived from cinchona, is a highly effective antimalarial agent against *Plasmodium falciparum*, though resistance has emerged, and it is now often used in combination therapies.

How it works

The proposed mechanism for cinchona's weight loss effects is primarily linked to its bitter taste agonist properties. These properties are hypothesized to modulate food intake and satiety signals by interacting with gut hormone pathways, such as those involving cholecystokinin. By stimulating bitter taste receptors, cinchona may influence the release of satiety hormones, thereby potentially reducing appetite and promoting a feeling of fullness. In the context of malaria, quinine, the principal alkaloid in cinchona, acts by interfering with the parasite's heme detoxification process, leading to its demise. While quinine's antimalarial action is well-understood, its specific metabolic effects in humans, beyond its bitter taste properties, are less comprehensively characterized. Quinine is known to be metabolized primarily in the liver by the cytochrome P450 3A4 enzyme, with various metabolites contributing to its overall activity.

Side effects

The cited randomized controlled trial on *Cinchona succirubra* supplementation for weight loss reported no significant adverse effects over 60 days of use in overweight adults, suggesting short-term tolerability at nutraceutical doses. However, it is crucial to note that quinine, the primary alkaloid in cinchona, has a narrow therapeutic index. At higher doses, quinine can lead to a constellation of adverse effects known as cinchonism, which includes symptoms such as tinnitus, headache, nausea, blurred vision, and dizziness. More severe effects can include cardiac arrhythmias and hypersensitivity reactions. Due to quinine's metabolism by the cytochrome P450 3A4 (CYP3A4) enzyme, there is a potential for drug interactions, particularly with other medications that are also metabolized by or inhibit/induce this pathway. Specific contraindications or detailed safety data for cinchona supplementation in the weight loss context, beyond the general pharmacology of quinine, were not extensively identified in the provided research. Long-term safety data for cinchona as a weight loss supplement are currently lacking.

Dosage

The specific dosage of *Cinchona succirubra* used in the randomized controlled trial for weight management was not detailed in the provided summary, though it was administered alongside a hypocaloric diet for 60 days. This indicates that the effective dose for weight loss benefits is within a range that was well-tolerated in the short term. It is important to distinguish this from the well-established, but much higher, dosages of quinine used for antimalarial treatment, which are not applicable to nutraceutical use. For weight loss or metabolic benefits, the optimal dosing, timing, and form of cinchona supplementation remain to be definitively established through further research. Currently, there are no widely accepted upper limits or safety thresholds specifically for cinchona as a weight loss supplement, and users should exercise caution and consult healthcare professionals.

FAQs

Is cinchona safe for weight loss?

Limited short-term data from one study suggest it's safe for overweight adults over 60 days. However, long-term safety and effects at higher doses are not yet known, and caution is advised.

Does cinchona work alone or only with diet?

Current evidence indicates that cinchona supplementation is beneficial for weight loss when combined with a hypocaloric diet, rather than as a standalone solution.

How fast do benefits appear?

Significant changes in weight and body composition were observed after 60 days of consistent supplementation in the primary research study.

Is quinine the active compound for weight loss?

While quinine is the principal alkaloid, the exact active components and their specific mechanisms for weight loss, beyond bitter taste agonism, require further clarification through research.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC10745730/ – This randomized controlled trial investigated *Cinchona succirubra* supplementation in overweight/obese adults. It found that supplementation combined with a hypocaloric diet significantly improved weight loss, body composition, and satiety compared to diet alone over 60 days, suggesting a role for bitter taste agonists in metabolic health.
https://pubmed.ncbi.nlm.nih.gov/38140292/ – This PubMed entry likely refers to the same RCT on *Cinchona succirubra* supplementation. It highlights the study's findings on improved body composition and satiety in overweight/obese individuals when cinchona was combined with a hypocaloric diet, supporting its potential as a weight management aid.
https://www.drugs.com/npp/quinine.html – This source provides a comprehensive pharmacological overview of quinine, the main alkaloid from cinchona. It details quinine's antimalarial properties, metabolism (CYP3A4), and potential drug interactions, emphasizing its narrow therapeutic index and the risk of toxicity at higher doses.
https://www.tandfonline.com/doi/full/10.2147/TCRM.S405507 – This article discusses the pharmacology of quinine, focusing on its use as an antimalarial drug. It covers its mechanism of action, pharmacokinetics, and adverse effects, providing a detailed understanding of quinine's clinical profile, though not directly related to weight loss applications.
https://www.isrctn.com/ISRCTN13055163 – This entry from the ISRCTN registry provides details about the clinical trial on *Cinchona succirubra* supplementation. It confirms the study's design and objectives, offering transparency and context for the research on cinchona's effects on weight management and metabolic parameters.